Common mistakes in life sciences localization and how to avoid them
Life sciences are one of the most complex and challenging localization niches anyone could take on — and because of this, there are many common…
→ Continue ReadingT
he increasing adoption of eConsent is revolutionizing clinical trials, offering greater convenience and transparency and improving patient compliance. But for trials involving linguistically and culturally diverse patient populations, successful implementation goes far beyond simply digitizing consent forms.
Challenges include
Failing to address these challenges can cause all sorts of problems, impacting patient enrollment, threatening trial success, and increasing the risk of noncompliance.
Contract research organizations (CROs) and sponsors face many challenges when executing clinical trials. Effectively and expertly adapting eConsent materials to suit patients is an invaluable way to ensure the best possible outcomes.
So, how can sponsors and CROs ensure that eConsent works across global markets?
Advertisement
Different agencies, such as the U.S. Food and Drug Administration and the European Medicines Agency, have their own regulatory standards and their own requirements for digital consent. Failure to comply with these requirements can delay trials or even result in rejection. To avoid these issues, it is best to ensure that
eConsent interfaces should be intuitive and accessible to ensure that all patients — regardless of education level, language, culture or digital literacy — can fully understand what they are consenting to.
Complex information can confuse patients, so use simplified language to improve understanding. Too much information can be overwhelming, so it’s important to break down complex information into digestible segments. Where possible, make the most of multimedia tools, such as videos or infographics, to display information in more engaging and easy-to-understand ways.
Protect sensitive participant information through robust cybersecurity measures and compliance with data protection regulations such as GDPR or HIPAA. To ensure data safety and security, choose an eConsent solution that includes
Consider regional and cultural differences that could affect how consent is perceived and understood, tailoring content accordingly. Certain terms, images, or concepts might not resonate across cultures, affecting patient trust and willingness to enroll.
Ensure that adequate technical support is available. Issues with software or hardware can hinder the consent process, leading to frustration for participants and staff. Partner with reliable technology providers and ensure robust testing of the eConsent platform before implementation. Provide immediate technical support to resolve issues as they arise.
Implementing eConsent in multilingual, global clinical trials requires a strategic approach — one that combines regulatory expertise, linguistic accuracy, and digital optimization. Localization specialists with life sciences expertise offer solutions that can enhance the eConsent process in several ways:
Advertisement
eConsent represents a significant advancement, streamlining the consent process and enhancing participant engagement. By addressing key considerations, overcoming common challenges, and leveraging the support services available through a specialist partnership, clinical trial sponsors can effectively implement eConsent solutions. Overall, this leads to improving participant understanding and compliance, which goes a long way to help deliver more successful trial outcomes.
Melissa May is a subject matter expert in Life Sciences at Acolad, specializing in clinical and biopharma. With 19 years of experience in the language services industry, she has focused on ensuring compliance, accuracy, and accessibility in global clinical trials.
Advertisement
Related Articles
Life sciences are one of the most complex and challenging localization niches anyone could take on — and because of this, there are many common…
→ Continue ReadingAcolad, the global leader in language and content solutions, has announced the expansion of its AI Data Services Solutions, marking a bold step in shaping…
→ Continue ReadingAcolad appoints industry veteran Manchandan Kaur Sandhu to lead its Life Sciences unit, driving growth across Europe, North America, and APAC.
→ Continue Reading